Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter.
Revascularization by percutaneous transluminal coronary angioplasty is limited in the long-term by restenosis, which is luminal renarrowing in the first 6 months after the procedure. Smooth muscle cell proliferation is thought to be an important factor in restenosis; this leads to neointima formation and arterial lumen narrowing. Local therapy delivered perivascularly may have an effect on events in the neointima and reduce restenosis. The effect of delivering expression vector plasmids for senescent cell-derived inhibitor SDI-1, which regulates cell proliferation, and its antisense, into the perivascular tissue of injured arteries was investigated in a porcine arterial injury model using a needle injection catheter. Transfection efficiency, biological effect and plasmid dissemination were evaluated in arterial and organ tissue sections between 2 days and 4 months. A limited number of adventitial, medial and neointimal cells were transfected up to 4 months. sdi gene transfer did not result in a change in neointima. Transfer of antisense sdi resulted in an increase in neointima after 3 weeks. No DNA plasmid was detected in control tissues. Liposomally-mediated adventitial local gene delivery is feasible and safe using the needle injection catheter in a porcine model. A limited number of cells was transfected, with expression of transfected genes up to 4 months after delivery. A transient biological effect with increased neointima was observed after delivery of the antisense sdi gene.
Huehns
T Y
TY
Medical Clinic I, Klinikum Grosshadern, Munich, Germany.
Krausz
E
E
Mrochen
S
S
Schmid
M
M
Engelmann
M G
MG
Esin
S
S
Schrittenloher
P K
PK
Höfling
B
B
Günzburg
W H
WH
Nikol
S
S
D000704:Analysis of Variance; D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D002404:Catheterization; D002453:Cell Cycle; D002455:Cell Division; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis; D004195:Disease Models, Animal; D005263:Femoral Artery / Q000166:cytology / Q000293:injuries; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D015552:Injections, Intralesional / Q000295:instrumentation; D008969:Molecular Sequence Data; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D010957:Plasmids / Q000008:administration & dosage* / Q000235:genetics; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity; D013552:Swine; D013556:Swine, Miniature; D013997:Time Factors; D017539:Tunica Intima / Q000166:cytology*
D004247:DNA